ST. LOUIS and LOS ANGELES, June 11, 2024 (GLOBE NEWSWIRE) -- Advantage Solutions Inc. (NASDAQ: ADV), a leading business solutions provider to consumer goods manufacturers and retailers, and L.A. Libations, a leading consumer packaged goods innovator, incubator and accelerator, today announced they have signed a letter of intent to form a joint venture that will bring the full power of Advantage’s suite of services on a national scale to emerging consumer packaged goods and beverage brands. The proposed joint venture, which is intended to be called Relentless Advantage, would combine Advantage’s industry-leading scale, insights, talent ...

The deployment will help Valeo develop the technologies needed to make the car more electrified, autonomous and software driven. It will also support the optimization of the company’s research and development expenses.

Sage Therapeutics announced today topline results from the Phase 2 SURVEYOR Study. The study met its primary endpoint demonstrating a statistically significant difference as measured by the HD-Cognitive Assessment Battery (HD-CAB) composite score at baseline between healthy participants and participants with Huntington’s Disease (HD) prior to any treatment with dalzanemdor (SAGE-718) or placebo.